Carson Pirie Scott extends expiration date of tender offer for Younkers.MILWAUKEE, Wisc.--(BUSINESS WIRE)--Feb. 3, 1995--Carson Pirie Scott & Co. (NYSE NYSE See: New York Stock Exchange :CRP C-reactive protein (CRP) A protein present in blood serum in various abnormal states, like inflammation. Mentioned in: Pelvic Inflammatory Disease CRP, n.pr See C-reactive protein. ) today announced that it has extended the expiration date of its tender offer for all of the outstanding common stock of Younkers Younkers is a department store chain in the Midwestern United States. The chain concentrates on the middle and upper-class segments of the market. History Beginnings Inc. (NASD-NMS: YONK) to 12:00 midnight, New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. time, on Thursday, March 2, 1995. Carson said that as of Thursday, Feb. 2, 1995, approximately 1,636,003 shares of Younkers common stock had been tendered into Carson's offer. These shares, together with the 1,047,500 shares of Younkers common stock owned by Carson, represent approximately 30% of Younkers's outstanding shares. Stanton J. Bluestone, president and chief executive officer of Carson, commented: "We are encouraged that a significant number of Younkers stockholders have tendered their shares. The number of tendered shares is especially impressive in light of the fact that Younker's 'poison pill' prohibits us from buying more than the 1,047,500 Younkers shares we already own. By tendering their shares, we believe the tendering stockholders are clearly expressing their displeasure with Younker's 'just say no' strategy." CONTACT: Carson Pirie Scott Carson Pirie Scott & Co., known informally as Carson's, is a chain of traditional department stores that have been in business for over 150 years. Their product price points are targeted to the moderate-to-upscale shopper. & Co. Darren R. Jackson, 414/278-5787 (Investors) or Edward P. Carroll, Jr., 414/347-5340 (media) or MacKenzie Partners Stanley J. Kay, 212/929-5940 (Investors) |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion